Brief: Lifemd, Inc. Reports Second Quarter 2022 Results
Aug 11 (Reuters) - LifeMD Inc LFMD.O :
* LIFEMD, INC. REPORTS SECOND QUARTER 2022 RESULTS
* Q2 ADJUSTED NON-GAAP LOSS PER SHARE $0.22
* Q2 REVENUE ROSE 37 PERCENT TO $30.5 MILLION
* REMAIN ON TRACK TO DELIVER CONSOLIDATED ADJUSTED EBITDA
PROFITABILITY BY Q4 2022
Source text for Eikon: ID:nGNX5LMXBK
Further company coverage: LFMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LifeMD
See all newsLifeMD Q1 revenue beats estimates on record telehealth subscriber additons
Brief: LifeMD Q1 Adjusted EBITDA USD -4.5 Million Vs. IBES Estimate USD -4.66 Million
LifeMD rises after adding new daily obesity pill to weight management program
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US (updated)
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US